More Post from the Author
- FinVolution Group Announces New Share Repurchase Program of Up to US$150 million
- Le Costa Rica redouble ses efforts de promotion des investissements en Europe dans les secteurs des technologies agricoles, des services mondiaux et des infrastructures touristiques
- Modular Building Institute Names Matt Slataper President of the Board of Directors
- ePlus Announces Fourth Quarter and Fiscal Year 2026 Earnings Release Date and Conference Call
- AARP Mississippi Applauds Passage and Signing of law to Protect Consumers from Cryptocurrency Kiosk Fraud
QuantalX Neuroscience Announces CE MDR Approval, Making Brain Health Assessment Available in the EU
Published on Wed 12 Feb 2025 8:06:42 UTC
The company announces CE MDR approval for its novel Delphi-MD neurodiagnosis medical device in preparation for EU commercialization, improving patients' clinical outcomes and well being while reducing healthcare systems and payors' financial burden.
NEW YORK, Feb. 12, 2025 /PRNewswire/ --QuantalX Neuroscience Ltd. is proud to announce that its groundbreaking brain health assessment device, the Delphi-MD, has received CE MDR approval, the European Union's certification under the new Medical Device Regulation (MDR). The CE MDR certification process sets a new benchmark for safety, efficacy, and quality in medical devices. This achievement underscores QuantalX's commitment to innovation and excellence in neurological care.
More Post from the Author
- FinVolution Group Announces New Share Repurchase Program of Up to US$150 million
- Le Costa Rica redouble ses efforts de promotion des investissements en Europe dans les secteurs des technologies agricoles, des services mondiaux et des infrastructures touristiques
- Modular Building Institute Names Matt Slataper President of the Board of Directors
- ePlus Announces Fourth Quarter and Fiscal Year 2026 Earnings Release Date and Conference Call
- AARP Mississippi Applauds Passage and Signing of law to Protect Consumers from Cryptocurrency Kiosk Fraud